Ra. Browning et al., ENHANCEMENT OF THE ANTICONVULSANT EFFECT OF FLUOXETINE FOLLOWING BLOCKADE OF 5-HT1A RECEPTORS, European journal of pharmacology, 336(1), 1997, pp. 1-6
Serotonin reuptake inhibitors, such as fluoxetine, have been shown to
exert anticonvulsant effects in several animal models of epilepsy. In
view of recent studies showing that 5-HT1A receptor antagonists (somat
odendritic autoreceptor antagonists) enhance the increase in extracell
ular 5-hydroxytryptamine (5-HT, serotonin) produced by serotonin reupt
ake inhibitors, it was of interest to determine if these antagonists a
lso enhance the anticonvulsant effect of fluoxetine in Genetically Epi
lepsy-Prone Rats (GEPRs). The 5-HT,, receptor antagonists(-)-pindolol
and LY 206130 l-4-yloxy]-3-[cyclohexylamino]-2-propanol-maleate) were
examined in the present study and both enhanced the anticonvulsant act
ion of fluoxetine in severe seizure GEPRs (GEPR-9s). The latter effect
of LY 206130 was found to be dose-and 5-HT-dependent. These findings
provide further evidence that the increase in extracellular serotonin
observed after administering fluoxetine in combination with a 5-HT,, r
eceptor antagonist is physiologically important and that the anticonvu
lsant effect of fluoxetine in the GEPR is mediated through an increase
in extracellular 5-HT. (C) 1997 Elsevier Science B.V.